Swedish spring and pressing manufacturer Lesjöfors Group has signed an agreement to acquire a 51 per cent stake in ...
IRVINE, Calif. - Edwards Lifesciences (NYSE:EW) reported fourth quarter earnings and revenue that beat analyst expectations, sending its shares up 4.2% in after-hours trading on Tuesday.
Rampant product commoditization throughout the oilfield-services industry will prevent ChampionX from developing and maintaining a competitive advantage. ChampionX holds a strong position in the ...
Hosted on MSN6d
NOV Earnings Transcript (NYSE:NOV)Presentation Operator Good day and good day, ladies and gentlemen, and thank you for standing-by. Welcome to the NOV ...
Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to ...
Paycom Software forecast full-year 2025 revenue below market estimates on Wednesday, as businesses cut back on spending for human capital management services, sending its shares down 3.3%.
Huawei’s latest revenue represents a robust 22 per cent year on year growth over 704.2 billion yuan posted in 2023. While Huawei is not a listed company, it discloses its financial data on a ...
Edwards Lifesciences (NYSE: EW) shares got a boost after hours today on fourth-quarter results that came in ahead of the consensus forecast.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback